Astrana Health, Inc. (ASTH) is a Medical - Care Facilities company in the Healthcare sector, currently trading at $29.07. It has a SharesGrow Score of 56/100, indicating a above average investment profile with 3 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of ASTH = $42.41 (+45.9% from the current price, the stock appears undervalued). Analyst consensus target is ASTH = $33 (+12.7% upside).
Valuation: ASTH trades at a trailing Price-to-Earnings (P/E) of 59.8 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 1.12.
Financials: revenue is $3.2B, +41.4%/yr average growth. Net income is $22M, growing at -14.1%/yr. Net profit margin is 0.7% (thin). Gross margin is 9.3% (-8.1 pp trend).
Balance sheet: total debt is $1.1B against $779M equity (Debt-to-Equity (D/E) ratio 1.38, moderate). Current ratio is 1.4 (adequate). Debt-to-assets is 48.6%. Total assets: $2.2B.
Analyst outlook: 8 / 9 analysts rate ASTH as buy (89%) — strong consensus.
SharesGrow 7-Criteria breakdown: Value 66/100 (Pass), Growth 58/100 (Partial), Past 100/100 (Pass), Health 33/100 (Fail), Moat 24/100 (Fail), Future 82/100 (Pass), Income 30/100 (Fail).
